申请人:Tianjin Medical University Cancer Institute and Hospital
公开号:US20170273933A1
公开(公告)日:2017-09-28
The invention disclose a compound of formula (I), wherein, R
1
is selected from —H or C1-C6 hydrocarbon group, —NH
2
, —OH, —O(CH
2
)
n
CH
3
(n=0, 1 or 2), —N(CH
3
)
2
, or —CH
2
N(CH
3
)
2
, R
2
is selected from an amino acid
or an hydroxy acid
or —OH (R
1
, R
2
are not —CH
3
and —OH at the same time), wherein X, Y are
—H, —CH
3
, —CH
2
OH, —CH(OH)CH
3
, —CH
2
SH, —CH(CH
3
)
2
, —CH
2
CH(CH
3
)
2
, —CH(CH
3
)CH
2
CH
3
, —CH
2
CH
2
SCH
3
, —CH
2
COOH, —CH
2
CONH
2
, —CH
2
CH
2
COOH, —CH
2
CH
2
CH
2
CH
2
NH
2
, or —CH
2
CH
2
CONH
2
, R
3
-R
5
are H or C1-C6 hydrocarbon group. The compound has a low toxicity, can significantly inhibit the migration and invasion of tumor cells in vitro, and can inhibit tumor metastasis in vivo in mice at low concentration, while showing notable sensitizing effect on cytotoxic anti-tumor drugs such as Paclitaxel etc.